Active

Mission BioCapital

Investor type

PE / VC

Founded

2015

AUM

$500 M

Location

Cambridge, Massachusetts, United States

Investment Ticket

$10-50 m

Investment Stage

Seed Series B

Region of investment

North America
Investor profile last updated: 09 February, 2026

Profile

BioInnovation Capital invests in the most promising life science companies in residence at premier co-working laboratory facilities where our partners are on-site every day. As the first investment platform to knit together a national network of co-working laboratories, we have a unique lens and an unparalleled position from which to invest. Our perspective is characterized by superb access to key innovators in academia, as well as to the corporate partners who are likely eventual homes for our investments. The geographic nature of innovation hubs and our overlapping network of facilities and resources, supports the formation of stellar companies from the most powerful universities, research institutions, hospitals and corporations in our sector.

Industry

Biotechnology Chemicals Healthcare Services Pharmaceuticals MedTech Life Sciences Infrastructure HealthTech Fashion/Beauty Food and Beverage Foodtech

Mission BioCapital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Mission BioCapital V LP
Fund of funds
Fashion/Beauty
Food and Beverage
Foodtech
Healthcare Services
HealthTech
Seed
Series A
Series B
North America
$5-10 m
$275 M
November 2021
Mission BioCapital VI Fund
Fund of funds
Fashion/Beauty
Food and Beverage
Foodtech
Healthcare Services
HealthTech
Seed
Series A
Series B
North America
$5-10 m
$134 M
September 2025

Contacts

Name
Title
Email
avatar
Eric W. Linsley BioInnovation Capital
BioInnovation Capital
-
Upgrade to see contacts
avatar
fzqGsUdaT8Ml24vH fzqGsUdaT8Ml24vH
fzqGsUdaT8Ml24vH
avatar
fzqGsUdaT8Ml24vH fzqGsUdaT8Ml24vH
fzqGsUdaT8Ml24vH
avatar
fzqGsUdaT8Ml24vH fzqGsUdaT8Ml24vH
fzqGsUdaT8Ml24vH
avatar
fzqGsUdaT8Ml24vH fzqGsUdaT8Ml24vH
fzqGsUdaT8Ml24vH
Investment-team contacts for Mission BioCapital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Mission BioCapital

Mission BioCapital is a venture capital and private equity firm. It backs companies at Seed and Series B, writing tickets of $10-50 m.
Mission BioCapital is located in Cambridge, Massachusetts, United States.
Mission BioCapital was founded in 2015.
Mission BioCapital invests in companies and startups in Biotechnology, Chemicals, Healthcare Services, Pharmaceuticals, MedTech, Life Sciences, Infrastructure, HealthTech, Fashion/Beauty, Food and Beverage, Foodtech.
Mission BioCapital invests in companies and startups in North America.
Mission BioCapital invests in companies and startups at Seed, Series B.
Mission BioCapital usually invests $10-50 m on average.
Mission BioCapital has around $500m assets under management.
Mission BioCapital last fund was created/launched in 2025-09-19
Mission BioCapital can be reached through its website missionbiocapital.com, its LinkedIn page and its X account. Its general enquiries address is info@missionbiocapital.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Mission BioCapital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Mission BioCapital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 09 February, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.